GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » MeCure Industries Plc (NSA:MECURE) » Definitions » Other Long-Term Liabilities

MeCure Industries (NSA:MECURE) Other Long-Term Liabilities : ₦0.00 Mil (As of . 20)


View and export this data going back to 2023. Start your Free Trial

What is MeCure Industries Other Long-Term Liabilities?

MeCure Industries's other long-term liabilities for the quarter that ended in . 20 was ₦0.00 Mil.


MeCure Industries Other Long-Term Liabilities Historical Data

The historical data trend for MeCure Industries's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MeCure Industries Other Long-Term Liabilities Chart

MeCure Industries Annual Data
Trend
Other Long-Term Liabilities

MeCure Industries Semi-Annual Data
Other Long-Term Liabilities

MeCure Industries Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.


MeCure Industries Other Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of MeCure Industries's Other Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


MeCure Industries Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
Apapa Oshodi Expressway, Me Cure House, Plot 6, Block H, Oshodi, Lagos, NGA
MeCure Industries Plc is a therapeutics company in the pharmaceutical industry in Lagos, Nigeria. It is principally engaged in the business of manufacturing drugs (tablets, capsules, and syrups) in Nigeria and consists of two categories namely Pharmaceuticals and Nutraceuticals. The Pharmaceuticals segment comprises forty-one (41) drugs such as Ebu 200 & 400 (ibuprofen tablets), Laclox (an anilox formulation), Lamox (an amoxicillin formulation), and Lampicin (an ampicillin formulation), used in treating different ailments. The Nutraceuticals segment consists of 100 products including multivitamins and dietary supplements.

MeCure Industries Headlines

No Headlines